Cite
HARVARD Citation
Zhang, F. et al. (2018). A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea. Annals of the rheumatic diseases. 77 (3), pp. 355-363. [Online].